Connect your AI

Pacira BioSciences, Inc. PCRX Common Stock

Common Stock at other companies

Avanos MedicalAVNS

300M0.0%

Collegium Pharmaceutical, Inc.COLL

100M+249,900%

AtriCureATRC

90M0.0%

Other financials

Income statement

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

Market cap$942.78M-16.0%

Enterprise value$1.21B+1.2%

P/E183.5×—

P/S1.3×-0.3×

Profitability

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pacira BioSciences, Inc.'s common stock?: Pacira BioSciences, Inc. (PCRX) reported common stock of 250M in Q1 2026.
How has Pacira BioSciences, Inc.'s common stock changed year-over-year?: Pacira BioSciences, Inc.'s common stock decreased by 0.0% year-over-year, from 250M to 250M.
What is the long-term trend for Pacira BioSciences, Inc.'s common stock?: Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock has grown at a 463.5% compound annual growth rate (CAGR), from 44K to 250M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).